stockportfolio.pro
Stocks / NTRA vs ZTS
NTRA vs ZTS
Natera, Inc. and Zoetis Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
ZTS is the larger company ($32.4B vs $31.0B). On the fundamentals, NTRA grows revenue faster (42.6% vs 7.2%); ZTS earns a higher net margin (28.2% vs -9.0%); ZTS has the stronger return on equity (78.3% vs -12.2%). Full numbers below — the stronger figure on each row is in green.
| Natera, Inc. (NTRA) | Zoetis Inc. (ZTS) | |
|---|---|---|
| Market cap | $31.0B | $32.4B |
| Revenue (latest FY) | $2.31B | $9.47B |
| Net income (latest FY) | $-208.16M | $2.67B |
| Revenue growth (5y CAGR) | 42.6% | 7.2% |
| Net margin | -9.0% | 28.2% |
| Return on equity | -12.2% | 78.3% |
| P/E ratio | — | 12.7 |
| Dividend yield | — | 2.7% |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | Yes | Yes |
Compare with another company:
See the full NTRA vs ZTS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open NTRA's full financials → Open ZTS's full financials →More comparisons
Frequently asked questions
Which is bigger, NTRA or ZTS?
Zoetis Inc. is larger by market capitalization — $32.4B versus $31.0B.
Which grows faster, NTRA or ZTS?
Over the last five fiscal years, Natera, Inc. grew revenue faster — 42.6%/yr versus 7.2%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.